Showing 1,441 - 1,460 results of 103,480 for search '(( 2 step decrease ) OR ( 5 ((((mg decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 1.51s Refine Results
  1. 1441
  2. 1442
  3. 1443
  4. 1444
  5. 1445
  6. 1446

    Modafinil treatment prevents METH-induced decrease in DAT immunoreactivity in the striatum. by Mariana Raineri (304307)

    Published 2013
    “…Average integrated density (% control) was determined in a region of interest in the dorsolateral striatum in mice (n = 5−8 sacrificed 48 hours (I) or 6 days (J) after the last METH injection. …”
  7. 1447
  8. 1448
  9. 1449
  10. 1450

    The estrogen receptor-α agonist PPT decreases cardiac myofilament activation. by Justyna Kulpa (313372)

    Published 2013
    “…Untreated controls showed no differences at any time, and are combined as a single group in each graph (N = 23). Maximum actomyosin MgATPase activity tended to decrease following PPT treatment, but did not reach statistical significance. …”
  11. 1451

    MVEC microvessel formation is restricted in hydrogels exhibiting increased stiffness or decreased concentration of adhesive peptides. by Rebecca A. Scott (488956)

    Published 2020
    “…An unpaired student’s t-test detect statistical significance, *p<0.05 for 7.5 wt% hydrogels containing 3 mM RGD relative to either (<b>A, C-F</b>) 15wt% hydrogels containing 3 mM RGD or (<b>G, I-L</b>) 7.5wt% hydrogels containing 1 mM RGD.…”
  12. 1452

    Ophthalmic administration of CXCR3 antagonist decreases intraocular pressure in a rat model of ocular hypertension. by Alexandre Denoyer (160189)

    Published 2012
    “…<p><i>(A)</i> A single administration of CXCR3 antagonist (NBI-74330, 1 µM, 100 µL) induces a transient decrease in intraocular pressure (n = 10 in each group). …”
  13. 1453

    FLCN-deficiency leads to decreased Rho activity in sub-confluent cells and delays in wound closure. by Doug A. Medvetz (300145)

    Published 2013
    “…<b>B)</b> Rho activity was measured using a Rhotekin binding assay at 70% confluence. The FLCN-null UOK257 cells had a 2.5-fold decrease in active Rho levels (Rho GTP) compared to the FLCN re-expressing UOK257-2 cells (n = 3, p<0.05). …”
  14. 1454
  15. 1455
  16. 1456

    N100 amplitude decrease during 1 Hz-rTMS. by Christian Helfrich (297785)

    Published 2013
    “…<p>(<b>A</b>) N100 amplitude reduction during 1 Hz-rTMS (group mean values). …”
  17. 1457

    PKRA7 decreases subcutaneous and intracranial glioblastoma xenograft tumor growth. by Valerie F. Curtis (276433)

    Published 2013
    “…<p>(<b>A</b>) D456MG cells were SC injected into nude mice, and control (n = 5) or PKRA7 (n = 5) treatment was commenced when tumors became visually detectable (14 days). …”
  18. 1458
  19. 1459
  20. 1460